Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2023-02-23 | 2023-05-06 | 185468 |
| APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2024-07-12 | 2024-07-26 | 232829 |
| APO-LEVOTHYROXINE | 50MCG | TABLET | Resolved | 2025-08-14 | 2025-11-07 | 265284 |
| APO-LEVOTHYROXINE | 175MCG | TABLET | Resolved | 2025-06-19 | 2025-08-22 | 260690 |
| APO-LEVOTHYROXINE | 125MCG | TABLET | Resolved | 2025-07-03 | 2025-10-24 | 261641 |
| APO-LEVOTHYROXINE | 150MCG | TABLET | Resolved | 2025-06-12 | 2025-10-10 | 260156 |
| APO-LEVOTHYROXINE | 175MCG | TABLET | Resolved | 2025-06-12 | 2025-08-22 | 260159 |
| APO-LEVOTHYROXINE | 100MCG | TABLET | Resolved | 2025-06-12 | 2025-10-10 | 260162 |
| APO-LEVOTHYROXINE | 200MCG | TABLET | Actual shortage | 2025-05-15 | 2026-01-15 | 257519 |
| APO-LEVOTHYROXINE | 137MCG | TABLET | Resolved | 2025-06-19 | 2025-10-31 | 260669 |
| APO-LEVOTHYROXINE | 125MCG | TABLET | Resolved | 2025-06-19 | 2025-10-31 | 260678 |
| APO-LEVOTHYROXINE | 137MCG | TABLET | Resolved | 2025-06-19 | 2025-10-10 | 260687 |
| APO-LEVOTHYROXINE | 200MCG | TABLET | Resolved | 2025-05-15 | 2025-07-18 | 257525 |
| APO-LEVOTHYROXINE | 112MCG | TABLET | Resolved | 2025-06-19 | 2025-11-07 | 260693 |
| APO-LEVOTHYROXINE | 100MCG | TABLET | Resolved | 2025-06-20 | 2025-10-16 | 260817 |
| APO-LEVOTHYROXINE | 88MCG | TABLET | Resolved | 2025-06-20 | 2025-10-31 | 260820 |
| APO-LEVOTHYROXINE | 88MCG | TABLET | Resolved | 2025-06-20 | 2025-10-10 | 260823 |
| APO-LEVOTHYROXINE | 50MCG | TABLET | Resolved | 2025-07-10 | 2025-11-14 | 262425 |
| APO-LEVOTHYROXINE | 75MCG | TABLET | Resolved | 2025-07-10 | 2025-10-10 | 262429 |
| APO-LEVOTHYROXINE | 150MCG | TABLET | Resolved | 2025-07-03 | 2025-10-10 | 261632 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
| APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
| APO-FENTANYL MATRIX | 25MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60489 |
| APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
| APO-FLUVOXAMINE TABLETS | 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4716 |
| APO-FLUVOXAMINE TABLETS | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4713 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2018-02-26 | 2018-02-26 | 40997 |
| APO-GEMFIBROZIL | 600MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4927 |
| APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
| APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
| APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
| APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
| APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |